Xenetic Biosciences, Inc. (XBIO) Balance Sheet
XBIO balance sheet, 2025
December 31, 2025 · U.S. dollars$8.4M assets = $968,025 liabilities + $7.4M equity
Both columns are drawn to the same scale: what XBIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
XBIO financial health
Descriptive bands, not a rating. Fiscal 2025.
XBIO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $21.0M2016 | $8.4M2025 | −9.7%/yr | |
| Total liabilities | $4.8M2016 | $968,0252025 | −16.3%/yr | |
| Shareholders’ equity | $16.2M2016 | $7.4M2025 | −8.3%/yr | |
| Cash & short-term investments | $4.0M2016 | $7.9M2025 | +7.7%/yr | |
| Total debt | $20,0422019 | $27,0432021 | +16.2%/yr | |
| Net cash (debt) | $10.3M2019 | $18.2M2021 | +$7.9M | |
| Working capital | $6.5M2016 | $7.1M2025 | +$609,247 | |
| Book value per share | $19.112020 | $4.352025 | −25.6%/yr | |
| Current ratio | 4.472016 | 8.322025 | +3.85 | |
| Debt / equity | 0.002019 | 0.002021 | 0.00 | |
| Shares outstanding | 639K2020 | 1.7M2025 | +21.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
XBIO assets
XBIO liabilities and equity
XBIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
XBIO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $7.9M | $6.2M | $9.0M | $13.1M | $18.2M | $11.5M | $10.4M | $571,605 | $5.5M | $4.0M |
| Cash & equivalents | $7.9M | $6.2M | $9.0M | $13.1M | $18.2M | $11.5M | $10.4M | $571,605 | $5.5M | $4.0M |
| Short-term investments | — | — | — | — | — | — | — | — | $67,000 | $67,000 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $500,000 | $0 | $0 | $0 | $3.0M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 |
| Other current assets | $166,294 | $421,954 | $603,828 | $556,094 | $479,399 | $341,958 | $722,079 | $622,366 | $351,515 | $1.3M |
| Total current assets | $8.0M | $6.6M | $9.6M | $13.7M | $18.7M | $12.4M | $11.1M | $1.2M | $5.9M | $8.3M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $27,043 | $20,799 | $4,956 | $27,846 | $42,366 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $18.5M | $12.5M | $12.5M | $12.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $313,921 | $313,921 | $1.0M | $1.1M | $1.1M | $782,942 | $0 | $705,660 | $724,713 | $66,342 |
| Total assets | $8.4M | $6.9M | $10.6M | $14.7M | $19.8M | $13.2M | $21.5M | $14.4M | $19.2M | $21.0M |
| Liabilities | ||||||||||
| Accounts payable | $258,109 | $283,615 | $240,832 | $287,360 | $362,470 | $327,396 | $931,128 | $934,147 | $786,779 | $1.0M |
| Short-term debt | — | — | — | — | $27,043 | $35,482 | $20,042 | — | — | — |
| Deferred revenue | — | — | — | — | −$27,043 | −$35,482 | −$20,042 | — | — | — |
| Total current liabilities | $968,025 | $894,263 | $809,585 | $1.1M | $1.4M | $936,928 | $1.4M | $1.6M | $1.9M | $1.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $287,360 | $362,470 | $27,043 | $2.9M | $2.9M | $2.9M | $2.9M |
| Total liabilities | $968,025 | $894,263 | $809,585 | $1.1M | $1.4M | $963,971 | $4.3M | $4.5M | $4.9M | $4.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $2,294 | $1,545 | $1,544 | $1,520 | $13,465 | $8,771 | $6,092 | $9,726 | $9,040 | $8,730 |
| Retained earnings (deficit) | −$199.9M | −$197.2M | −$193.2M | −$189.1M | −$182.5M | −$176.9M | −$166.0M | −$153.2M | −$145.9M | −$142.3M |
| Treasury stock | — | — | — | — | — | −$5.3M | −$5.3M | −$5.3M | −$5.3M | −$5.3M |
| Accumulated other comprehensive income | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 |
| Total shareholders' equity | $7.4M | $6.0M | $9.8M | $13.6M | $18.4M | $12.2M | $17.2M | $9.9M | $14.3M | $16.2M |
| Key figures | ||||||||||
| Total debt | — | — | — | — | $27,043 | $62,525 | $20,042 | — | — | — |
| Net cash (debt) | — | — | — | — | $18.2M | $11.5M | $10.3M | — | — | — |
| Working capital | $7.1M | $5.7M | $8.8M | $12.6M | $17.3M | $11.4M | $9.7M | −$405,817 | $3.9M | $6.5M |
| Tangible book value | $7.4M | $6.0M | $9.8M | $13.6M | $18.4M | $12.2M | −$1.3M | −$2.6M | $1.8M | $3.6M |
| Book value per share | $4.35 | $3.90 | $6.41 | $9.59 | $17.89 | $19.11 | — | — | — | — |
| Shares outstanding | 1.7M | 1.5M | 1.5M | 1.4M | 1.0M | 639K | — | — | — | — |
| Current ratio | 8.32 | 7.37 | 11.84 | 12.72 | 13.18 | 13.20 | 7.84 | 0.75 | 3.03 | 4.47 |
| Quick ratio | 8.14 | 6.89 | 11.10 | 12.20 | 12.84 | 12.84 | 7.33 | 0.36 | 2.85 | 3.78 |
| Debt / equity | — | — | — | — | 0.00 | 0.01 | 0.00 | — | — | — |
| Equity / assets | 88.4% | 87.0% | 92.4% | 92.7% | 92.8% | 92.7% | 79.9% | 68.7% | 74.6% | 77.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $6.5M | $7.3M | $7.9M | $4.1M | $4.8M | $5.2M | $6.2M | $6.8M | $7.3M | $7.8M | $9.0M | $9.8M |
| Cash & equivalents | $6.5M | $7.3M | $7.9M | $4.1M | $4.8M | $5.2M | $6.2M | $6.8M | $7.3M | $7.8M | $9.0M | $9.8M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $716,381 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$716,381 | $0 | $0 | $0 |
| Other current assets | $182,311 | $247,815 | $166,294 | $946,361 | $573,854 | $313,620 | $421,954 | $188,088 | $716,381 | $552,042 | $603,828 | $1.5M |
| Total current assets | $6.7M | $7.6M | $8.0M | $5.1M | $5.4M | $5.5M | $6.6M | $7.0M | $8.0M | $8.4M | $9.6M | $11.3M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $313,921 | $313,921 | $313,921 | $0 | $0 | $313,921 | $313,921 | $1.0M | $1.0M | $1.0M | $1.0M | $704,431 |
| Total assets | $7.0M | $7.9M | $8.4M | $5.1M | $5.4M | $5.8M | $6.9M | $8.0M | $9.0M | $9.4M | $10.6M | $12.0M |
| Liabilities | ||||||||||||
| Accounts payable | $322,537 | $558,808 | $258,109 | $578,250 | $346,828 | $240,293 | $283,615 | $243,343 | $283,586 | $210,483 | $240,832 | $448,558 |
| Total current liabilities | $894,977 | $958,239 | $968,025 | $1.1M | $903,430 | $667,927 | $894,263 | $1.0M | $1.6M | $716,494 | $809,585 | $1.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $894,977 | $958,239 | $968,025 | $1.1M | $903,430 | $667,927 | $894,263 | $1.0M | $1.6M | $716,494 | $809,585 | $1.1M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2,346 | $2,294 | $2,294 | $1,545 | $1,545 | $1,545 | $1,545 | $1,545 | $1,544 | $1,544 | $1,544 | $1,536 |
| Retained earnings (deficit) | −$201.3M | −$200.3M | −$199.9M | −$199.3M | −$198.8M | −$198.1M | −$197.2M | −$196.1M | −$195.7M | −$194.4M | −$193.2M | −$192.1M |
| Accumulated other comprehensive income | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,734 | $253,733 | $253,734 | $253,734 |
| Total shareholders' equity | $6.1M | $7.0M | $7.4M | $4.0M | $4.5M | $5.1M | $6.0M | $7.0M | $7.4M | $8.7M | $9.8M | $10.9M |
| Key figures | ||||||||||||
| Working capital | $5.8M | $6.6M | $7.1M | $4.0M | $4.5M | $4.8M | $5.7M | $6.0M | $6.4M | $7.7M | $8.8M | $10.2M |
| Tangible book value | $6.1M | $7.0M | $7.4M | $4.0M | $4.5M | $5.1M | $6.0M | $7.0M | $7.4M | $8.7M | $9.8M | $10.9M |
| Book value per share | $2.65 | $3.03 | $3.23 | $2.57 | $2.89 | $3.32 | $3.90 | $4.56 | $4.83 | $5.63 | $6.37 | $7.11 |
| Shares outstanding | 2.3M | 2.3M | 2.3M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M |
| Current ratio | 7.43 | 7.93 | 8.32 | 4.56 | 5.93 | 8.20 | 7.37 | 6.96 | 5.05 | 11.69 | 11.84 | 10.54 |
| Quick ratio | 7.23 | 7.67 | 8.14 | 3.71 | 5.29 | 7.73 | 6.89 | 6.78 | 5.05 | 10.92 | 11.10 | 9.15 |
| Equity / assets | 87.2% | 87.9% | 88.4% | 78.1% | 83.1% | 88.5% | 87.0% | 87.5% | 82.4% | 92.4% | 92.4% | 91.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.
XBIO financial position
At the end of fiscal 2025 (December 31, 2025), Xenetic Biosciences had total assets of $8.4 million (up 21.2% from a year earlier), total liabilities of $1.0 million and shareholders' equity of $7.4 million. Its current ratio was 8.32. In the latest quarter (ended June 30, 2026) total assets were $7.0 million and equity $6.1 million.
Related: XBIO income statement, XBIO cash flow statement, XBIO key metrics. See the XBIO stock overview for the latest quote and news.
XBIO balance sheet FAQ
What are Xenetic Biosciences's total assets?
Xenetic Biosciences reported total assets of $8.4 million at the end of fiscal 2025 (December 31, 2025), compared with $6.9 million a year earlier.
How much cash does Xenetic Biosciences have?
Xenetic Biosciences held $7.9 million in cash and short-term investments at the end of fiscal 2025.
What is Xenetic Biosciences's book value?
Xenetic Biosciences's shareholders' equity (book value) was $7.4 million at the end of fiscal 2025, or $4.35 per share.
What is Xenetic Biosciences's current ratio?
Xenetic Biosciences had current assets of $8.0 million and current liabilities of $1.0 million, a current ratio of 8.32 (it can cover its short-term obligations).